User profiles for P. Buckhaults

Phillip Buckhaults

The University of South Carolina
Verified email at sc.edu
Cited by 14298

Early-onset colorectal cancer: initial clues and current views

…, EA Murphy, M Sajish, A Sheth, PJ Buckhaults… - Nature reviews …, 2020 - nature.com
Over the past several decades, the incidence of early-onset colorectal cancer (EOCRC; in
patients <50 years old) has increased at an alarming rate. Although robust and scientifically …

The genomic landscapes of human breast and colorectal cancers

…, DR Smith, E Suh, N Papadopoulos, P Buckhaults… - Science, 2007 - science.org
Human cancer is caused by the accumulation of mutations in oncogenes and tumor suppressor
genes. To catalog the genetic changes that occur during tumorigenesis, we isolated …

The consensus coding sequences of human breast and colorectal cancers

…, N Silliman, S Szabo, P Buckhaults, C Farrell, P Meeh… - science, 2006 - science.org
The elucidation of the human genome sequence has made it possible to identify genetic
alterations in cancers in unprecedented detail. To begin a systematic analysis of such …

[PDF][PDF] Human Smad3 and Smad4 are sequence-specific transcription activators

L Zawel, J Le Dai, P Buckhaults, S Zhou, KW Kinzler… - Molecular cell, 1998 - cell.com
Mounting evidence indicates that Smad proteins are required for TGFβ signaling, but the
way(s) in which Smad proteins propagate this signal is unclear. We found that two human …

A phosphatase associated with metastasis of colorectal cancer

S Saha, A Bardelli, P Buckhaults, VE Velculescu… - Science, 2001 - science.org
To gain insights into the molecular basis for metastasis, we compared the global gene
expression profile of metastatic colorectal cancer with that of primary cancers, benign colorectal …

Serum macrophage inhibitory cytokine 1 as a marker of pancreatic and other periampullary cancers

J Koopmann, P Buckhaults, DA Brown… - Clinical Cancer …, 2004 - AACR
… CA19–9 (area under the receiver operating characteristic curve, 0.81 and 0.77, respectively),
and the combination of MIC-1 and CA19–9 significantly improved diagnostic accuracy (P < …

[HTML][HTML] Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer

…, S Aksoy, A Akyol, A Uner, PJ Buckhaults… - Nature …, 2020 - nature.com
Chemoresistance is a major obstacle in triple negative breast cancer (TNBC), the most
aggressive breast cancer subtype. Here we identify hypoxia-induced ECM re-modeler, lysyl …

MIC-1 serum level and genotype: associations with progress and prognosis of colorectal carcinoma

DA Brown, RL Ward, P Buckhaults, T Liu… - Clinical Cancer …, 2003 - AACR
Purpose: Macrophage inhibitory cytokine-1 (MIC-1) is a divergent member of the tumor growth
factor β (TGF-β) superfamily. Several observations suggest that it plays a role in colorectal …

Secreted and cell surface genes expressed in benign and malignant colorectal tumors

P Buckhaults, C Rago, B St. Croix, KE Romans, S Saha… - Cancer research, 2001 - AACR
Serial analysis of gene expression was used to identify transcripts encoding secreted or cell
surface proteins that were expressed in benign and malignant tumors of the colorectum. A …

Analysis of the matrix metalloproteinase family reveals that MMP8 is often mutated in melanoma

…, CE Banister, JD Howard, P Buckhaults… - Nature …, 2009 - nature.com
A mutational analysis of the matrix metalloproteinase (MMP) gene family in human melanoma
identified somatic mutations in 23% of melanomas. Five mutations in one of the most …